Close

Search

Search Menu
Photonics Media Photonics Marketplace Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Genetix

Facebook Twitter LinkedIn Email Comments
Imaging and image analysis solutions provider Genetix of New Milton, UK, has received US patent No. 7,776,584, aspects of which have been incorporated into the company’s ClonePix FL, a system used for screening and selection of cell lines producing biopharmaceuticals. Significantly reducing the time and cost associated with recombinant protein generation, the system has been validated for the specific detection of secreted antibodies as well as monomeric, cell surface and intrinsic GFP fusion proteins.

BioPhotonics
Oct 2010
antibodiesbiopharmaceuticalsBiophotonicsBusinesscell surfaceClonePix FLenergyGenetixImage Analysisimaginginstrinsic GFP fusion proteinsmonomericpatentRapidScanrecombinant proteins generationscreeningselection of cell linesUK

Comments
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2021 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.